ArticleInternational journal of experimental pathology2022

lncRNA MIAT targets miR-411-5p/STAT3/PD-L1 axis mediating hepatocellular carcinoma immune response.

Xiaoxia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.